Osteogenic differentiation of human turbinate mesenchymal stromal cells

Tissue Engineering and Regenerative Medicine

Volumn 8, Issue 6, 2011, Pages 544-553

  Hwang, Se Hwan ^a   Kim, Su Young ^a   Park, Sun Hwa ^a   Choi, Mi Young ^a   Back, Sang A ^a   Kim, Yu Im ^a   Sun, Dong Il ^a   Kim, Sung Won ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Bone morphogenic protein 2; Human turbinate mesenchymal stromal cell,1,25 dihydroxyvitamin D3; Osteogenic differentiation

Indexed keywords

1 ,25-DIHYDROXYVITAMIN D3; BONE MORPHOGENETIC PROTEINS; MESENCHYMAL STROMAL CELLS; MORPHOGENIC; OSTEOBLASTIC DIFFERENTIATION; OSTEOGENESIS-RELATED GENES; OSTEOGENIC DIFFERENTIATION; REVERSE TRANSCRIPTASE- POLYMERASE CHAIN REACTION;

ASSAYS; BIOMATERIALS; BONE; CELLS; FLOWCHARTING; GENE EXPRESSION; PHOSPHATASES; POLYMERASE CHAIN REACTION; TISSUE;

CELL CULTURE;

EID: 84875552382     PISSN: 17382696     EISSN: 22125469     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. I Sekiya, DC Colter, DJ Prockop, BMP-6 enhances chondrogenesis in a subpopulation of human marrow stromal cells, Biochem Biophys Res Commun, 284, 411 (2001).
2. F Barry, RE Boynton, B Liu, et al., Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation- dependent gene expression of matrix components, Exp Cell Res, 268, 189 (2001).
3. GR Erickson, JM Gimble, DM Franklin, et al., Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo, Biochem Biophys Res Commun, 290, 763 (2002).
4. A Winter, S Breit, D Parsch, et al., Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells, Arthritis Rheum, 48, 418 (2003).
5. SE Haynesworth, J Goshima, VM Goldberg, et al., Characterization of cells with osteogenic potential from human marrow, Bone, 13, 81 (1992).
6. SW Kim, JH Cho, MW Hong, et al., Induction of chondrogenic differentiation in cultured fibroblasts isolated from the inferior turbinate, Otolaryngol Head Neck Surg, 139, 143 (2008).
7. JP van Leeuwen, M van Driel, GJ van den Bemd, et al., Vitamin D control of osteoblast function and bone extracellular matrix mineralization, Crit Rev Eukaryot Gene Expr, 11, 199 (2001).
8. D Chen, M Zhao, GR Mundy, Bone morphogenetic proteins, Growth Factors, 22, 233 (2004).
9. V Rosen, BMP2 signaling in bone development and repair, Cytokine Growth Factor Rev, 20, 475 (2009).
10. TA Owen, MS Aronow, LM Barone, et al., Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures, Endocrinology, 128, 1496 (1991).
11. V Shalhoub, F Aslam, E Breen, et al., Multiple levels of steroid hormone-dependent control of osteocalcin during osteoblast differentiation: glucocorticoid regulation of basal and vitamin D stimulated gene expression, J Cell Biochem, 69, 154 (1998).
12. JB Lian, GS Stein, The developmental stages of osteoblast growth and differentiation exhibit selective responses of genes to growth factors (TGF beta 1) and hormones (vitamin D and glucocorticoids), J Oral Implantol, 19, 95 (1993).
13. RG Erben, AM Scutt, D Miao, et al., Short-term treatment of rats with high dose 1,25-dihydroxyvitamin D3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow, Endocrinology, 138, 4629 (1997).
14. F Ohl, M Jung, C Xu, et al., Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?, J Mol Med, 83, 1014 (2005).
15. RS Tuan, G Boland, R Tuli, Adult mesenchymal stem cells and cell-based tissue engineering, Arthritis Res Ther, 5, 32 (2003).
16. JG Toma, M Akhavan, KJ Fernandes, et al., Isolation of multipotent adult stem cells from the dermis of mammalian skin, Nat Cell Biol, 3, 778 (2001).
17. SC Leong, R Eccles, Inferior turbinate surgery and nasal airflow: evidence-based management, Curr Opin Otolaryngol Head Neck Surg, 18, 54 (2010).
18. H Gocmen, H Oguz, K Ceylan, et al., Infected inferior turbinate pneumatization, Eur Arch Otorhinolaryngol, 262, 979 (2005).
19. G Berger, M Balum-Azim, D Ophir, The normal inferior turbinate: histomorphometric analysis and clinical implications, Laryngoscope, 113, 1192 (2003).
20. M Fradis, S Malatskey, I Magamsa, et al., Effect of submucosal diathermy in chronic nasal obstruction due to turbinate enlargement, Am J Otolaryngol, 23, 332 (2002).
21. AS Ketcham, JK Han, Complications and management of septoplasty, Otolaryngol Clin North Am, 43, 897 (2010).
22. XQ Jiang, JG Chen, S Gittens, et al., The ectopic study of tissue-engineered bone with hBMP-4 gene modified bone marrow stromal cells in rabbits, Chin Med J (Engl), 118, 281 (2005).
23. C Maniatopoulos, J Sodek, AH Melcher, Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats, Cell Tissue Res, 254, 317 (1988).
24. AK Born, M Rottmar, S Lischer, et al., Correlating cell architecture with osteogenesis: first steps towards live single cell monitoring, Eur Cell Mater, 18, 49 (2009).
25. YD Halvorsen, D Franklin, AL Bond, et al., Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells, Tissue Eng, 7, 729 (2001).
26. YS Zhou, YS Liu, JG Tan, Is 1, 25-dihydroxyvitamin D3 an ideal substitute for dexamethasone for inducing osteogenic differentiation of human adipose tissue-derived stromal cells in vitro?, Chin Med J (Engl), 119, 1278 (2006).
27. C Knabe, C Koch, A Rack, et al., Effect of beta-tricalcium phosphate particles with varying porosity on osteogenesis after sinus floor augmentation in humans, Biomaterials, 29, 2249 (2008).
28. T Komori, H Yagi, S Nomura, et al., Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts, Cell, 89, 755 (1997).
29. WY Baek, JE Kim, Transcriptional regulation of bone formation, Front Biosci (Schol Ed), 3, 126 (2011).
30. A Yamaguchi, T Komori, T Suda, Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1, Endocr Rev, 21, 393 (2000).
31. T Sakou, Bone morphogenetic proteins: from basic studies to clinical approaches, Bone, 22, 591 (1998).
32. JN Beresford, CJ Joyner, C Devlin, et al., The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro, Arch Oral Biol, 39, 941 (1994).
33. SL Cheng, SF Zhang, LV Avioli, Expression of bone matrix proteins during dexamethasone-induced mineralization of human bone marrow stromal cells, J Cell Biochem, 61, 182 (1996).
34. CD Hoemann, H El-Gabalawy, MD McKee, In vitro osteogenesis assays: influence of the primary cell source on alkaline phosphatase activity and mineralization, Pathol Biol (Paris), 57, 318 (2009).
35. MT Tsai, WJ Li, RS Tuan, et al., Modulation of osteogenesis in human mesenchymal stem cells by specific pulsed electromagnetic field stimulation, J Orthop Res, 27, 1169 (2009).
36. S Jootar, N Pornprasertsud, S Petvises, et al., Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion, Leuk Res, 30, 1493 (2006).
37. M Knippenberg, MN Helder, B Zandieh Doulabi, et al., Osteogenesis versus chondrogenesis by BMP-2 and BMP-7 in adipose stem cells, Biochem Biophys Res Commun, 342, 902 (2006).
38. RS Carpenter, LR Goodrich, DD Frisbie, et al., Osteoblastic differentiation of human and equine adult bone marrow-derived mesenchymal stem cells when BMP-2 or BMP-7 homodimer genetic modification is compared to BMP-2/7 heterodimer genetic modification in the presence and absence of dexamethasone, J Orthop Res, 28, 1330 (2010).
39. RJ Kroeze, M Knippenberg, MN Helder, Osteogenic differentiation strategies for adipose-derived mesenchymal stem cells, Methods Mol Biol, 702, 233 (2011).
40. T Noshi, T Yoshikawa, M Ikeuchi, et al., Enhancement of the in vivo osteogenic potential of marrow/hydroxyapatite composites by bovine bone morphogenetic protein, J Biomed Mater Res, 52, 621 (2000).
41. IJ De Kok, KC Hicok, RJ Padilla, et al., Effect of vitamin D pretreatment of human mesenchymal stem cells on ectopic bone formation, J Oral Implantol, 32, 103 (2006).
42. LR Chaudhary, AM Hofmeister, KA Hruska, Differential growth factor control of bone formation through osteoprogenitor differentiation, Bone, 34, 402 (2004).
43. HJ Lee, A Wislocki, C Goodman, et al., A novel vitamin D derivative activates bone morphogenetic protein signaling in MCF10 breast epithelial cells, Mol Pharmacol, 69, 1840 (2006).
44. HJ Lee, H Liu, C Goodman, et al., Gene expression profiling changes induced by a novel gemini vitamin D derivative during the progression of breast cancer, Biochem Pharmacol, 72, 332 (2006).
45. C Faucheux, R Bareille, J Amedee, et al., Effect of 1,25(OH)2D3 on bone morphogenetic protein-3 mRNA expression, J Cell Biochem, 73, 11 (1999).
46. CK Hee, SB Nicoll, Endogenous bone morphogenetic proteins mediate 1alpha, 25-dihydroxyvitamin D(3)-induced expression of osteoblast differentiation markers in human dermal fibroblasts, J Orthop Res, 27, 162 (2009).